![Pejvack Motlagh](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Pejvack Motlagh is currently Chief Medical Officer at Genfit SA since 2025.
Formerly, Dr. Motlagh was Chief Medical Officer at Egle Therapeutics SAS.
Postes actifs de Pejvack Motlagh
| Sociétés | Poste | Début |
|---|---|---|
| GENFIT | Directeur Technique/Scientifique/R&D | 27/11/2025 |
Anciens postes connus de Pejvack Motlagh
| Sociétés | Poste | Fin |
|---|---|---|
Egle Therapeutics SAS
 Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
6
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Genfit SA
 Genfit SA BiotechnologyHealth Technology Engages in research and development of medicines and diagnostic solutions | Health Technology |
Egle Therapeutics SAS
Egle Therapeutics SAS BiotechnologyHealth Technology Operates as a biotechnology company that designs modulate regulatory T cells to balance immunity for the treatment of cancer and autoimmune diseases | Health Technology |
